genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2007
Wyeth Pharmaceuticals
News
Pharmacopeia and Wyeth to Develop JAK3 Inhibitors
News
Wyeth’s Renal Cell Carcinoma Drug Gets NDA Priority Review Status
News
Wyeth Pharmaceuticals Continues Licensing Spree
News
Genedata Installs Large-Scale Analysis Platform at Wyeth
News
Philadelphia Court Awarded Plaintiff $1.5M in Prempro Hormone Replacement Case
Insights
Bringing Pharmacogenomics into the Clinic
News
Cardinal Health Inks Cell Line Development Deal with Wyeth
Insights
Combating the R&D Productivity Decline
Insights
Making Innovation Work in Drug Discovery
1
2
3
4
Page 4 of 4
Scroll Up